These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8355510)

  • 1. Decreased blood flow to rat bone marrow, bone, spleen, and liver in acute leukemia.
    Iversen PO; Thing-Mortensen B; Nicolaysen G; Benestad HB
    Leuk Res; 1993 Aug; 17(8):663-8. PubMed ID: 8355510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous nitric oxide causes vasodilation in rat bone marrow, bone, and spleen during accelerated hematopoiesis.
    Iversen PO; Nicolaysen G; Benestad HB
    Exp Hematol; 1994 Dec; 22(13):1297-302. PubMed ID: 7957715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing bone marrow micro-environment during development of acute myeloid leukaemia in rats.
    Mortensen BT; Jensen PO; Helledie N; Iversen PO; Ralfkiaer E; Larsen JK; Madsen MT
    Br J Haematol; 1998 Jul; 102(2):458-64. PubMed ID: 9695960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose cyclophosphamide treatment of acute myelocytic leukemia. Studies in the BNML rat model.
    Hagenbeek A; Martens AC
    Eur J Cancer Clin Oncol; 1982 Aug; 18(8):763-9. PubMed ID: 6759141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The leukopoietic cytokine granulocyte colony-stimulating factor increases blood flow to rat bone marrow.
    Iversen PO; Nicolaysen G; Benestad HB
    Exp Hematol; 1993 Feb; 21(2):231-5. PubMed ID: 7678810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrous oxide selectively reduces the proliferation of the malignant cells in experimental rat leukemia.
    Ermens AA; Vink N; Schoester M; van Lom K; Lindemans J; Abels J
    Cancer Lett; 1989 May; 45(2):123-8. PubMed ID: 2731156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone and bone-marrow blood flow in chronic granulocytic leukemia and primary myelofibrosis.
    Lahtinen R; Lahtinen T; Romppanen T
    J Nucl Med; 1982 Mar; 23(3):218-24. PubMed ID: 6950031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro erythroid colony formation in acute myelogenous leukemia in the rat.
    Handler ES; Handler EE
    J Natl Cancer Inst; 1976 Apr; 56(4):851-3. PubMed ID: 1062627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to non-invasive blood flow measurement in bone.
    Brookes M
    Biomed Eng; 1974 Aug; 9(8):342-7. PubMed ID: 4604119
    [No Abstract]   [Full Text] [Related]  

  • 10. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between inert gas wash-out and radioactive tracer microspheres in measurement of bone blood flow: effect of decreased arterial supply and venous congestion on bone blood flow in an animal model.
    Kiaer T; Dahl B; Lausten GS
    J Orthop Res; 1993 Jan; 11(1):28-35. PubMed ID: 8380853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BN acute myelocytic leukemia (BNML) (a rat model for studying human acute myelocytic leukemia (AML)).
    Martens AC; Van Bekkum DW; Hagenbeek A
    Leukemia; 1990 Apr; 4(4):241-57. PubMed ID: 2195239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCG treatment of residual disease in acute leukemia: studies in a rat model for human acute myelocytic leukemia (BNML).
    Hagenbeek A; Martens AC
    Leuk Res; 1983; 7(4):547-55. PubMed ID: 6578394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of daunomycin in leukemia cells and leukocytes in vivo in the rat.
    Sonneveld P; Kokenberg E; van der Steuijt K; Nooter K
    Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1109-16. PubMed ID: 3477464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hemorrhage on blood flow to marrow and osseous tissue in conscious rabbits.
    Syftestad GT; Boelkins JN
    Am J Physiol; 1980 Mar; 238(3):H360-4. PubMed ID: 7369381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative studies on graft-versus-leukemia after allogeneic bone marrow transplantation in rat models for acute myelocytic and lymphocytic leukemia.
    Kloosterman TC; Tielemans MJ; Martens AC; van Bekkum DW; Hagenbeek A
    Bone Marrow Transplant; 1994 Jul; 14(1):15-22. PubMed ID: 7951103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dual effect of curcumin on etoposide action in leukemic and healthy bone marrow cells of rats with acute myeloid leukemia.
    Papiez MA; Krzyściak W
    Folia Med Cracov; 2014; 54(2):71-9. PubMed ID: 25648312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditions controlling long-term proliferation of Brown Norway rat promyelocytic leukemia in vitro: primary growth stimulation by microenvironment and establishment of an autonomous Brown Norway 'leukemic stem cell line'.
    Lacaze N; Gombaud-Saintonge G; Lanotte M
    Leuk Res; 1983; 7(2):145-54. PubMed ID: 6574296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the heterogeneity of minimal residual disease in acute leukemia.
    Hagenbeek A; Martens AC
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():9-12. PubMed ID: 2713565
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of minimal disease in acute leukemia using flow cytometry: studies in a rat model for human acute leukemia.
    Martens AC; Hagenbeek A
    Cytometry; 1985 Jul; 6(4):342-7. PubMed ID: 3860369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.